Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1–8 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
2seventy bio Inc. Abecma (idecabtagene vicleucel) - (KarMMa-2) Newly diagnosed multiple myeloma Phase 2 Ongoing Intravenous Oncology
2seventy bio Inc. Abecma (idecabtagene vicleucel) - (KarMMa-9) Newly Diagnosed Multiple Myeloma Phase 2 Trial Discontinued Intravenous Oncology
3M Company EscharEx - (VALUE) Venous leg ulcers (VLU’s) Phase 3 Ongoing Topical Wound Care
4D Molecular Therapeutics Inc. 4D-150 - (4FRONT-2) wet AMD Phase 3 Trial Planned intravitreal Opthalmic
4D Molecular Therapeutics Inc. 4D-150 - (SPECTRA) Wet Age-Related Macular Degeneration (wet AMD) Phase 3 Data Released Intravitreal Opthalmic
4D Molecular Therapeutics Inc. 4D-150 - (PRISM) Wet age-related macular degeneration (AMD) Phase 2b Data Released Intravitreal injection Opthalmic
4D pharma plc Blautix (MRx1234) Irritable bowel syndrome (IBS) Phase 2 Oral Gastroenterology
4D pharma plc MRx0518 with bavencio (avelumab) 1L Urothelial carcinoma Phase 2 Intravenous Oncology